会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • (20R)-2a-Methyl-19,26,27-Trinor-Vitamin D Analogs
    • (20R)-2a-甲基-19,26,27-三维 - 维生素D类似物
    • US20080300223A1
    • 2008-12-04
    • US12171085
    • 2008-07-10
    • Hector F. DeLucaPawel GrzywaczLori A. PlumMargaret Clagett-Dame
    • Hector F. DeLucaPawel GrzywaczLori A. PlumMargaret Clagett-Dame
    • A61K31/59C07C403/06A61K31/593A61P35/00A61P37/00A61P3/10
    • C07C401/00
    • This invention discloses (20R)-2α-methyl-19,26,27-trinor-vitamin D analogs, and specifically (20R)-2α-methyl-19,26,27-trinor-1α,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits transcription activity as well as pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also shows very low activity in vivo on bone calcium mobilization and intestinal calcium transport activity compared to the native hormone 1α,25-dihydroxyvitamin D3, and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity.
    • 本发明公开了(20R)-2α-甲基-19,26,27-三硝基维生素D类似物,特别是(20R)-2α-甲基-19,26,27-三硝基-1α,25-二羟基维生素D 3和药物 用它。 该化合物显示转录活性以及阻止未分化细胞增殖并诱导其分化为单核细胞的显着活性,因此证明其用作抗癌剂并用于治疗皮肤疾病如牛皮癣以及皮肤病症如 皱纹,皮肤松弛,皮肤干燥,皮脂分泌不足。 与天然激素1α,25-二羟基维生素D 3相比,该化合物在体内对钙钙动员和肠钙运输活性的活性也显示出非常低的活性,因此可用于治疗人类的自身免疫性疾病或炎症性疾病以及肾性骨营养不良。 该化合物也可用于治疗或预防肥胖症。